Healthcare & Life Sciences

SpringWorks Therapeutics

aliveseries-c-plus
series-c-plus
Stage
3
Investors

About

SpringWorks Therapeutics develops targeted oncology therapies for rare cancers and severe diseases, focusing on novel treatments such as gamma secretase inhibitors and combination therapies in collaboration with industry and academia.

Explore SpringWorks Therapeutics's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.